Dublin Medtech start-up wins €2.7m in funding

Dublin Medtech start-up wins €2.7m in funding

Oncomark’s diagnostic tech helps breast cancer patients avoid unnecessary chemotherapy

Done deal:€2.7m funding

The clincher: “This award will enable us to accelerate the OncoMasTR test from the laboratory to the clinic, as well as creating employment opportunities.” - Des O’Leary, chief executive, OncoMark

Diagnostic technology that could help breast cancer patients avoid unnecessary post-operative chemotherapy has earned a Dublin start-up €2.7 million in funding.

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post